Loading...
OTCM
MNZO
Market cap109kUSD
Jul 28, Last price  
0.00USD
1D
0.00%
Jan 2017
0.00%
IPO
-96.43%
Name

Manzo Pharmaceuticals Inc

Chart & Performance

D1W1MN
OTCM:MNZO chart
No data to show
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
%
Revenues
Net income
CFO

Profile

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.
IPO date
Jul 11, 2001
Employees
12
Domiciled in
CA
Incorporated in
US

Valuation

No data to show